早期非小细胞肺癌立体定向体部放疗后远处转移与区域淋巴结复发的剂量学参数
本研究回顾性分析2017至2019年在本机构接受立体定向体部放疗的304例早期非小细胞肺癌患者(325个病灶),评估剂量学参数与远处转移及区域淋巴结复发的相关性。未发现PTV外30毫米壳层平均EQD2与远处转移率相关;在4-5次分割亚组中,该壳层平均EQD2≥21 Gy与远处转移发生率增加相关(HR 2.42,95%CI 1.06-5.53,p=0.04),与既往报道相反。
要点
- PTV外30毫米壳层平均EQD2与远处转移率无显著相关。
- PTV<22 cc(对比≥22 cc,p=0.01)和GTV<10 cc(对比≥10 cc,p<0.01)是远处转移减少的阳性预测因素。
- 4-5次分割亚组中,壳层平均EQD2≥21 Gy与远处转移增加相关(HR 2.42,95%CI 1.06-5.53,p=0.04)。
核心结论
- 未观察到PTV外剂量与远处转移率的相关性,与既往报道不同;在4-5次分割患者中观察到相反趋势。
- 数据显示远处转移与肿瘤大小存在额外相关性。
研究设计与样本
- 回顾性分析2017至2019年在本机构接受SBRT的304例患者(325个病灶),影像学推测或活检证实的早期NSCLC。
- 评估剂量学参数包括处方剂量、PTV最小和平均剂量、适形指数及PTV外30毫米壳层平均EQD2。
- 采用单变量Cox回归分析参数与区域淋巴结复发及远处转移率的相关性。
主要发现
- PTV外30毫米壳层平均EQD2与远处转移率无显著相关。
- 单变量Cox分析显示,PTV<22 cc(对比≥22 cc,p=0.01)和GTV<10 cc(对比≥10 cc,p<0.01)是远处转移减少的阳性预测因素。
- GTV<10 cc也是区域淋巴结复发减少的阳性预测因素(p<0.01)。
- 4-5次分割亚组中,壳层平均EQD2≥21 Gy与远处转移发生率增加相关(HR 2.42,95%CI 1.06-5.53,p=0.04)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Previous studies have suggested that the dose immediately outside the PTV may impact the incidence of distant metastases after stereotactic body radiation therapy (SBRT) for patients with early-stage non-small cell lung cancer (NSCLC). In particular, Diamant et al. [1,2] reported a correlation between the mean EQD2 of a 30 mm shell around the PTV and both local control and the rate of distant metastases. In this study, we assess this parameter and others in a series of patients with radiographically presumed or biopsy-proven early-stage NSCLC treated at our institution with stereotactic body radiotherapy (SBRT) between 2017 and 2019. MATERIALS/METHODS: We reviewed the dosimetry, local control, regional nodal relapse, and rate of distant metastases for 304 patients with 325 lesions treated with SBRT at our institution. Dosimetric parameters investigated include the prescribed dose, minimum and mean doses to the PTV, conformity index, and the mean EQD2 to a 30 mm shell around the PTV. Time to each event was defined from date of last fraction of SBRT to date of event, with event-free patients censored at last radiographic follow-up. Univariate (UVA) Cox regression analysis was performed on the collected parameters to assess for correlation with regional nodal relapse and rate of distant metastases. RESULTS: There was no significant correlation between the mean EQD2 dose to a 30 mm shell around the PTV and the rate of distant metastases. On UVA Cox proportional hazards analysis, positive predictors of reduced incidence of distant metastases were PTV <22 cc (vs. ≥22 cc, p = 0.01) and GTV <10 cc (vs. ≥10 cc, p < 0.01), with GTV <10 cc also being a positive predictor of reduced incidence of regional nodal relapse (p < 0.01). In the subset of patients treated with 4-5 fractions, mean EQD2 dose to the 30 mm shell around the PTV ≥21 Gy was associated with increased incidence of distant metastases (HR 2.42, 95% CI 1.06-5.53, p = 0.04), differing from prior data from Diamant et al. CONCLUSIONS: We did not observe a correlation between the rate of distant metastases and dose outside the PTV, as reported by other groups; rather, we noted an opposite trend in patients treated with 4-5 fractions. Our data show additional correlations between distant metastases and tumor size.
引用
- Lalonde R, Abdelhakiem M, Keller A, et al. Dosimetric parameters related to occurrence of distant metastases and regional nodal relapse after SBRT for early-stage non-small cell lung cancer. Radiother Oncol. 2022. PMID: 35202740. doi:10.1016/j.radonc.2022.02.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。